Dennis Scanlon


Distinguished Professor of Health Policy and Administration


  • Health & Medicine

Focus Areas:

  • Health Policy


  • Dennis Scanlon is available to broadly comment on topics such as COVID-19 vaccine policy and regulation, the need for a centralized health data system for supporting research and treatment of COVID-19, and the role of institutions and individual health care providers in improving patient outcomes.

Dennis Scanlon is a Distinguished Professor of Health Policy and Administration and the director of the Center for Health Care and Policy Research. Scanlon’s research focuses on the role of quality improvement and incentives in changing healthcare outcomes such as clinical quality, patient experience, and economic efficiency.

During the COVID-19 pandemic, Scanlon has been providing public commentary on the regulatory process in the United States for testing the COVID-19 vaccine candidates to determine their efficacy and effectiveness and on how an Emergency Use Authorization can help speed up the approval for expedited distribution to the population. He has also commented on the ethical issues and other potential challenges faced in distributing a limited vaccine supply in the United States and globally.

In The Media

“No matter how you slice it, there's uncertainty, and there are costs and benefit trade-offs. That sounds perhaps to some a little bit crass, but really trying to weigh the risk, what level of risk may be worth taking, and what are the costs to mitigate that risk."

Need help finding an expert?

Penn State expertise spans far beyond those that we have currently featured on the site. Call us at 814-865-7517 or contact a member of the media relations staff

Go to top